Monday 9 November 2026 Export IKT’s income statement to Excel — free account

Inhibikase Therapeutics, Inc.

IKT

Inhibikase Therapeutics, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $260,500.00, up 111.1% from fiscal 2022.

EPS: 0.00%
Free cash flow: −123.2%

Quarter to June 2026, against a year earlier

Revenue growth 3 yrs

1.50 0.06 +4.17%

Follow IKT

Alert me

Market cap: $209.3M
P/E: n/m
Fwd P/E: n/m
Dividend yield: —
F-score: 3/9
ROIC: 0.00%
Net debt / EBITDA: 3.4×
Dividend safety: n/a

Overview

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	—	—	—	—
EV/Sales Full definition →		—	—	—	—
EV/FCF Full definition →		—	—	—	—
Quick Ratio Full definition →		11.55	21.54	29.83	15.50
Current Ratio Full definition →		11.73	21.70	30.14	15.82
Net Debt/EBITDA Full definition →		6.07	12.98	9.55	7.55
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.89	0.59	0.74	0.64
Capex/Depreciation Full definition →		0.00	0.00	—	—
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Free Cash Flow Yield Full definition →		—	—	—	—
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.12)	(0.08)	(0.07)	(0.07)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.12)	(0.08)	(0.07)	(0.07)
Cash per Share Full definition →		0.86	1.82	0.99	0.91
Shareholders Equity per Share Full definition →		0.81	1.76	0.97	0.88
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		0.81	1.76	0.97	0.88
Free Cash Flow Full definition →		(10.59)	(7.52)	(12.06)	(12.44)
Working Capital Full definition →		71.84	171.81	166.46	152.08
Capital Expenditures Full definition →		0.00	0.00	—	—
Net Current Asset Value Full definition →		71.84	171.81	166.46	152.08
EV/EBIT Full definition →		—	—	—	—
Capex to Sales Full definition →		0.00	0.00	—	—
Other line items
Average Payables Full definition →		1.57	1.05	1.64	1.85
Average Assets Full definition →		41.99	139.90	133.81	126.22
Average Common Equity Full definition →		36.18	133.89	126.68	116.69

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026

Stockrow Weekly